| NCT ID | NCT06026345 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medtronic Cardiac Ablation Solutions |
| Condition | Atrial Fibrillation |
| Study Type | OBSERVATIONAL |
| Enrollment | 540 participants |
| Start Date | 2023-12-22 |
| Primary Completion | 2028-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 540 participants in total. It began in 2023-12-22 with a primary completion date of 2028-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Affera Global Registry is a prospective, global, multi-center, observational post-market registry (PMR). The purpose of this study is to describe clinical performance and safety data in a broad patient population treated with the Affera Platform.
Eligibility Criteria
Inclusion Criteria: * Subject is ≥ 18 years of age or minimum age as required by local regulations * Planned procedure using the commercially available Affera Platform * Willing and able to comply with study requirements and give IC (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements Exclusion Criteria: * Subject is enrolled in a concurrent study that has not been approved for concurrent enrollment by the global study manager * Subject with exclusion criteria required by local law
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06026345 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Atrial Fibrillation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06026345 currently recruiting?
Yes, NCT06026345 is actively recruiting participants. Contact the research team at libby.bergmann@medtronic.com for enrollment information.
Where is the NCT06026345 trial being conducted?
This trial is being conducted at Brussels, Belgium, Prague, Czechia, Prague, Czechia, Bordeaux, France and 8 additional locations.
Who is sponsoring the NCT06026345 clinical trial?
NCT06026345 is sponsored by Medtronic Cardiac Ablation Solutions. The trial plans to enroll 540 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.